| Role |
Name |
Disclosure |
Details |
| Author | Leslie L Citrome, MD, MPH, Director of Clinical Research and Evaluation Facility, Nathan Kline Inst, Department of Psychiatry, Professor of Psychiatry, New York University School of Medicine | Abbott AstraZeneca AstraZeneca Bristol-Myers Squibb Forest Janssen Jazz Eli Lilly Eli Lilly Eli Lilly Pfizer Pfizer Pfizer | Details | | Medical Editor | Jennifer S Berg, MD, Program Director, Department of Psychiatry, Naval Medical Center San Diego; Assistant Clinical Professor, Department of Psychiatry, University of California at San Diego | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | David Bienenfeld, MD, Vice-Chair, Program Director, Professor, Department of Psychiatry, Wright State University School of Medicine | Nothing to disclose | Details | | CME Editor | Harold H Harsch, MD, Program Director of Geropsychiatry, Department of Geriatrics/Gerontology, Associate Professor, Department of Psychiatry and Department of Medicine, Froedtert Hospital, Medical College of Wisconsin | lilly BMS Forest Labs AstraZeneca Pfizer Northstar Novartis | Details | | Chief Editor | Stephen Soreff, MD, President of Education Initiatives, Nottingham, NH; Faculty, Metropolitan College of Boston University, Boston, MA | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Jennifer S Berg, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| David Bienenfeld, Managing Editor |
The contributor discloses no conflict of interest. |
|